crizanlizumab

FDA Approves Crizanlizumab: Here Is A New Drug For Sickle Cell Disease
Forbes
Sun, 11/17/19 - 08:42 pm
Novartis
Adakveo
FDA
crizanlizumab
sickle cell disease
Novartis secures speedy review for sickle cell drug
Biopharma Dive
Tue, 07/16/19 - 12:05 pm
Novartis
sickle cell disease
FDA
crizanlizumab
Novartis May Beat Ironwood Pharmaceuticals to the Punch
Motley Fool
Tue, 10/30/18 - 11:17 pm
Novartis
crizanlizumab
sickle cell disease
Ironwood Pharmaceuticals
IW-1701
Novartis drug cuts serious complications in sickle cell disease
CP WIre
Wed, 10/10/18 - 10:15 am
Novartis
sickle cell disease
crizanlizumab
What makes a PhII drug worth up to $665M? Researchers spell it out for Novartis
Endpoints
Mon, 12/5/16 - 09:48 am
Novartis
crizanlizumab
sickle cell disease
M&A
Selexys